Compare Stocks

BELLUS Health Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. BELLUS Health Inc. was incorporated in 1993 and is based in Laval, Canada. As of June 28, 2023, BELLUS Health Inc. operates as a subsidiary of GSK plc.

Calamos Global Total Return Fund is a closed ended balanced mutual fund launched by Calamos Investments LLC. It is managed by Calamos Advisors LLC. The fund invests in public equity and fixed income markets across the globe. It seeks to invest in securities of companies operating across diversified sectors. The fund primarily invests in equities, convertible bonds, and high yield corporate bonds. It employs both fundamental and quantitative analysis to create its portfolio. The fund benchmarks the performance of its portfolio against MSCI World Index. Calamos Global Total Return Fund was formed on March 30, 2004 and is domiciled in the United States.

Marriott International, Inc. engages in operating, franchising, and licensing hotel, residential, timeshare, and other lodging properties worldwide. It operates its properties under the JW Marriott, The Ritz-Carlton, The Luxury Collection, W Hotels, St. Regis, EDITION, Bvlgari, Marriott Hotels, Sheraton, Westin, Autograph Collection, Renaissance Hotels, Le Méridien, Delta Hotels by Marriott, Tribute Portfolio, Gaylord Hotels, Design Hotels, Marriott Executive Apartments, Apartments by Marriott Bonvoy, Courtyard by Marriott, Fairfield by Marriott, Residence Inn by Marriott, SpringHill Suites by Marriott, Four Points by Sheraton, TownePlace Suites by Marriott, Aloft Hotels, AC Hotels by Marriott, Moxy Hotels, Element Hotels, Protea Hotels by Marriott, and City Express by Marriott brand names, as well as operates residences, timeshares, and yachts. The company was founded in 1927 and is headquartered in Bethesda, Maryland.

TCW Strategic Income Fund, Inc. is a close-ended balanced mutual fund launched by The TCW Group, Inc. The fund is managed by TCW Investment Management Company. It invests in the public equity and fixed income markets of the United States. The fund makes its investments in securities of companies operating across diversified sectors. For its equity investments, it seeks to invest in growth and value stocks of companies. The fund's fixed income investments are comprised of mortgage related securities, asset-backed securities, money market securities, convertible securities, high yield bonds, collateralized debt obligations (CDOs), and securities issued or guaranteed by the United States Government, its agencies and instrumentalities. It benchmarks the performance of its portfolio against the S&P 500 Index, NASDAQ, and a customized benchmark comprised of Barclays U.S. Aggregate Bond Index, Citigroup High Yield Cash Pay Index, S&P 500 Index, and BofA Merrill Lynch All Convertibles All Qualities. The fund was previously known as TCW Convertible Securities Fund, Inc. TCW Strategic Income Fund, Inc. was formed on January 13, 1987 and is domiciled in the United States.

USG Corporation, through its subsidiaries, manufactures and sells building materials worldwide. The company's Gypsum division manufactures and markets gypsum and related products to construct walls and ceilings of residential, nonresidential, and institutional buildings; and agricultural and industrial customers. This segment offers gypsum wallboards and compound portfolios, as well as corner beads, joint tapes, and plasters under the USG Sheetrock brand; glass mat sheathing portfolios under the Securock brand; construction plaster products under the Red Top, Imperial, Diamond, and Supremo brands; and lightweight gypsum panels under the USG Sheetrock brand, as well as ultralight panels, USG Sheetrock brand ecosmart panels, and industrial gypsum. Its Performance Materials division manufactures and markets products for interior and exterior building applications of residential and nonresidential buildings, as well as industrial applications. This segment provides cement boards, backer boards, shower systems, performance floorings, air barrier systems, roof board portfolios, and structural panels under the USG Durock, Fiberock, Levelrock, Securock, ExoAir, Securock, and USG brands. The company's Ceilings division manufactures and markets ceiling tiles under the Radar, Eclipse, Mars, and Halcyon brands; ceiling grids under the Donn, DX, Fineline, Centricitee, and Identitee DXI brands; specialty ceilings under the Curvatura, Compasso, Radians, Illusions, Multiples, Runways, Barz, Planx, Mirra, Corniche, Wallforms, and Parti brands; and acoustical drywall ceilings under the Ensemble brand. Its USG Boral Building Products division manufactures, distributes, and sells building products, mines raw gypsum, and sells natural and synthetic gypsum under the USG Boral Sheetrock, USG Boral NextGen, Elephant, Jayaboard, Durock, and Donn DX brands. The company was founded in 1902 and is headquartered in Chicago, Illinois.